Proton Beams to Replace Photon Beams in Radical Dose Treatments
- 1 December 2003
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 42 (8) , 800-808
- https://doi.org/10.1080/02841860310017676
Abstract
With proton beam radiation therapy a smaller volume of normal tissues is irradiated at high dose levels for most anatomic sites than is feasible with any photon technique. This is due to the Laws of Physics, which determine the absorption of energy from photons and protons. In other words, the dose from a photon beam decreases exponentially with depth in the irradiated material. In contrast, protons have a finite range and that range is energy dependent. Accordingly, by appropriate distribution of proton energies, the dose can be uniform across the target and essentially zero deep to the target and the atomic composition of the irradiated material. The dose proximal to the target is lower compared with that in photon techniques, for all except superficial targets. This resultant closer approximation of the planning treatment volume (PTV) to the CTV/GTV (grossly evident tumor volume/subclinical tumor extensions) constitutes a clinical gain by definition; i.e. a smaller treatment volume that covers the target three dimensionally for the entirety of each treatment session provides a clinical advantage. Several illustrative clinical dose distributions are presented and the clinical outcome results are reviewed briefly. An important technical advance will be the use of intensity modulated proton radiation therapy, which achieves contouring of the proximal edge of the SOBP (spread out bragg peak) as well as the distal edge. This technique uses pencil beam scanning. To permit further progressive reductions of the PTV, 4-D treatment planning and delivery is required. The fourth dimension is time, as the position and contours of the tumor and the adjacent critical normal tissues are not constant. A potentially valuable new method for assessing the clinical merits of each of a large number of treatment plans is the evaluation of multidimensional plots of the complication probabilities for each of ‘n’ critical normal tissues/structures for a specified tumor control probability. The cost of proton therapy compared with that of very high technology photon therapy is estimated and evaluated. The differential is estimated to be ≈1.5 provided there were to be no charge for the original facility and that there were sufficient patients for operating on an extended schedule (6–7 days of 14–16 h) with ≥ two gantries and one fixed horizontal beam.Keywords
This publication has 14 references indexed in Scilit:
- Radiation-induced second cancers: the impact of 3D-CRT and IMRTPublished by Elsevier ,2003
- Evidence-Based Estimates of Outcome in Patients Irradiated for Intraocular MelanomaArchives of Ophthalmology (1950), 2002
- The Gray Lecture 2001: coming technical advances in radiation oncologyInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Relative biological effectiveness (RBE) values for proton beam therapyPublished by Elsevier ,2002
- Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanomaInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Chondrosarcoma of the Base of the SkullThe American Journal of Surgical Pathology, 1999
- Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Proton therapy for tumors of the skull baseStrahlentherapie und Onkologie, 1999
- Supplementary Treatment of Nasopharyngeal Tumours with High Energy ProtonsActa Radiologica, 1967
- Radiological Use of Fast ProtonsRadiology, 1946